<span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">The global biologics Contract Development and Manufacturing Organization (CDMO) market has witnessed remarkable growth in recent years and continues to gain momentum. Valued at USD 17.26 billion in 2023, the market is expected to expand at a Compound Annual Growth Rate (CAGR) of 9.12% during the forecast period, reaching USD 34.64 billion by 2031. This upward trajectory highlights increasing demand for biologics, advancements in biomanufacturing technologies, and the strategic shift of pharmaceutical companies toward outsourcing to specialized CDMOs.</span>

<h3>[size= 12.0pt; font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin]Market Overview[/size]</h3>
<span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">In Biologics CDMO Market, There are specialized firms that provide outsourced services for the development and manufacturing of complex biological drugs, including monoclonal antibodies, vaccines, cell and gene therapies, and recombinant proteins. With the biopharmaceutical industry evolving rapidly, the demand for flexible and scalable manufacturing solutions has significantly increased. CDMOs offer biotech and pharmaceutical companies the ability to accelerate timelines, reduce capital investment, and gain access to high-end technologies and expertise.</span>

<h3>[size= 12.0pt; font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin]Key Market Trends[/size]</h3>
<span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">The biologics CDMO market is influenced by several key trends that shape its growth and innovation path:</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l3 level1 lfo1; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Rising Biologic Drug Approvals:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Regulatory approvals for biologic-based therapies have surged, encouraging pharmaceutical companies to scale up production through CDMOs.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l3 level1 lfo1; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Growth in Cell and Gene Therapies:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Innovative therapies such as CAR-T, mRNA vaccines, and gene editing tools are driving demand for specialized manufacturing capabilities.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l3 level1 lfo1; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Shift Toward Outsourcing:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Biopharma companies increasingly prefer outsourcing due to cost-efficiency, lack of in-house infrastructure, and complex regulatory requirements.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l3 level1 lfo1; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Technology Integration:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Adoption of single-use bioreactors, digital manufacturing platforms, and process automation are revolutionizing biologics production.</span>

<h3>[size= 12.0pt; font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin]Market Demand and Drivers[/size]</h3>
<span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">The rising prevalence of chronic diseases, increased R&D investments, and the emergence of biosimilars are fueling demand for biologics manufacturing support:</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l5 level1 lfo2; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Growing Chronic Disease Burden:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Increasing cases of cancer, autoimmune disorders, and infectious diseases necessitate advanced biologic treatments.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l5 level1 lfo2; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Personalized Medicine:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Demand for precision therapeutics is boosting development of niche biologics requiring flexible manufacturing platforms.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l5 level1 lfo2; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">COVID-19 Pandemic Aftermath:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> The success of mRNA vaccines has heightened global focus on biologics, encouraging long-term investments in production capacity.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l5 level1 lfo2; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Patent Expirations and Biosimilars:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> As blockbuster biologics approach patent cliffs, biosimilar development surges, requiring scalable CDMO support.</span>

<h3>[size= 12.0pt; font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin]Market Dynamics[/size]</h3>
<span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">The biologics CDMO market is characterized by strong competition, technological innovation, and strategic partnerships. Key market dynamics include:</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l2 level1 lfo3; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Strategic Collaborations:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Increasing joint ventures and long-term service agreements between CDMOs and pharmaceutical giants.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l2 level1 lfo3; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Capacity Expansion:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> CDMOs are investing heavily in expanding production facilities, especially in microbial and mammalian expression systems.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l2 level1 lfo3; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Talent and Skill Shortages:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> The high technical complexity of biologics manufacturing presents workforce challenges, boosting the value of CDMO expertise.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l2 level1 lfo3; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Regulatory Challenges:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Stringent regulations, especially around advanced therapies, create high entry barriers and emphasize quality-driven CDMO operations.</span>

<h3>[size= 12.0pt; font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin]Future Outlook[/size]</h3>
<span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">The biologics CDMO market is poised for exponential growth, driven by scientific breakthroughs and market forces. Future projections suggest:</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l7 level1 lfo4; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Expansion into Emerging Markets:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Asia-Pacific, particularly India and China, is becoming a key hub due to cost advantages and improving regulatory frameworks.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l7 level1 lfo4; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">AI and Big Data Integration:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Predictive analytics and AI-driven process optimization will enhance production efficiency and product quality.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l7 level1 lfo4; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Sustainable Manufacturing:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Environmental sustainability is becoming a priority, pushing CDMOs to adopt greener processes and energy-efficient facilities.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l7 level1 lfo4; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Increased Focus on Rare Diseases:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> CDMOs will play a critical role in manufacturing orphan biologics with small-batch, high-value requirements.</span>

<h3>[size= 12.0pt; font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin]Market Segmentation[/size]</h3>
<span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">The biologics CDMO market is segmented based on service type, product type, and end-user industry:</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l1 level1 lfo5; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">By Service Type:</span>

<p style="margin-left: 72.0pt; text-indent: -18.0pt; mso-list: l1 level2 lfo5; tab-stops: list 72.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New']o<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Process Development</span>

<p style="margin-left: 72.0pt; text-indent: -18.0pt; mso-list: l1 level2 lfo5; tab-stops: list 72.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New']o<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Analytical Testing</span>

<p style="margin-left: 72.0pt; text-indent: -18.0pt; mso-list: l1 level2 lfo5; tab-stops: list 72.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New']o<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Fill & Finish Operations</span>

<p style="margin-left: 72.0pt; text-indent: -18.0pt; mso-list: l1 level2 lfo5; tab-stops: list 72.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New']o<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Manufacturing Services (Upstream and Downstream)</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l1 level1 lfo5; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">By Product Type:</span>

<p style="margin-left: 72.0pt; text-indent: -18.0pt; mso-list: l1 level2 lfo5; tab-stops: list 72.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New']o<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Monoclonal Antibodies</span>

<p style="margin-left: 72.0pt; text-indent: -18.0pt; mso-list: l1 level2 lfo5; tab-stops: list 72.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New']o<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Vaccines</span>

<p style="margin-left: 72.0pt; text-indent: -18.0pt; mso-list: l1 level2 lfo5; tab-stops: list 72.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New']o<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Recombinant Proteins</span>

<p style="margin-left: 72.0pt; text-indent: -18.0pt; mso-list: l1 level2 lfo5; tab-stops: list 72.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New']o<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Cell & Gene Therapies</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l1 level1 lfo5; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">By End-User:</span>

<p style="margin-left: 72.0pt; text-indent: -18.0pt; mso-list: l1 level2 lfo5; tab-stops: list 72.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New']o<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Biopharmaceutical Companies</span>

<p style="margin-left: 72.0pt; text-indent: -18.0pt; mso-list: l1 level2 lfo5; tab-stops: list 72.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New']o<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Research Institutions</span>

<p style="margin-left: 72.0pt; text-indent: -18.0pt; mso-list: l1 level2 lfo5; tab-stops: list 72.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New']o<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Academic Centers</span>

<h3>[size= 12.0pt; font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin]Key Market Players[/size]</h3>
<span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">The competitive landscape of the biologics CDMO market is highly consolidated, with major players focusing on expanding capabilities and global footprint. Leading companies include:</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Lonza Group AG</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Samsung Biologics</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">WuXi Biologics</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Boehringer Ingelheim BioXcellence</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Catalent Inc.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Fujifilm Diosynth Biotechnologies</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Thermo Fisher Scientific Inc.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Samsung Biologics</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">AGC Biologics</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Abzena Ltd</span>

<span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">These players are engaged in capacity building, geographic expansion, mergers, and acquisition strategies to strengthen their market presence.</span>

<h3>[size= 12.0pt; font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin]Recent Developments[/size]</h3>
<span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Several notable developments have taken place that signal the market's continued expansion:</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l6 level1 lfo7; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Lonza&rsquo;s expansion</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> of its biologics manufacturing facility in Switzerland to support large-scale commercial production.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l6 level1 lfo7; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">WuXi Biologics&rsquo; investments</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> in U.S. and European plants to enhance global service offerings.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l6 level1 lfo7; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Catalent&rsquo;s acquisition</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> of cell and gene therapy manufacturers to diversify its biologics portfolio.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l6 level1 lfo7; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Thermo Fisher&rsquo;s partnerships</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> with biotech innovators to co-develop next-generation biologics.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l6 level1 lfo7; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Samsung Biologics&rsquo; announcement</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> of building its fifth and largest biomanufacturing plant in South Korea.</span>

<h3>[size= 12.0pt; font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin]Regional Analysis[/size]</h3>
<span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">The biologics CDMO market is geographically diverse, with North America dominating due to its advanced biotech infrastructure and strong demand for novel biologics. However, significant growth is being observed across other regions:</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l4 level1 lfo8; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">North America:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Largest market share, driven by R&D intensity, established biopharma sector, and regulatory clarity.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l4 level1 lfo8; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Europe:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Growth led by robust healthcare systems and investments in biotech innovation, especially in Germany, Switzerland, and the UK.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l4 level1 lfo8; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Asia-Pacific:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Fastest-growing region, spurred by government incentives, low-cost manufacturing, and increasing clinical trial activities.</span>

<p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l4 level1 lfo8; tab-stops: list 36.0pt;"><!-- [if !supportLists]-->[size= 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol]&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> [/size]</span><!--[endif]--><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Latin America & Middle East:</span><span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Emerging opportunities due to healthcare modernization and increasing biologics awareness.</span>

<span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Conclusion</span>

<span style="font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">The global biologics CDMO market is on an impressive growth trajectory, fueled by the convergence of technological innovation, rising biologics demand, and strategic outsourcing trends. As the pharmaceutical landscape continues to evolve toward complex biologics and precision therapies, CDMOs will play a pivotal role in delivering scalable, compliant, and cost-effective manufacturing solutions. With strong growth prospects and dynamic industry shifts, stakeholders across the biopharma value chain are closely watching this space for strategic opportunities.</span>

[size= 12pt; line-height: 106%; font-family: Calibri, sans-serif]Get Full Detailed PDF Report- https://www.kingsresearch.com/biologics-cdmo-market-1995[/size]